LENZ Therapeutics

Lenz Therapeutics is a late-stage clinical company based in Solana Beach, California, founded in 2021. The company is focused on developing innovative ophthalmic pharmaceutical products, with its lead product, vizz (aceclidine ophthalmic solution) 1.44%, being the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia, a condition affecting an estimated 1.8 billion people globally.